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testing is inexpensive, approximately 50 percent of those diagnosed will present with late stage disease at the
time of diagnosis. Women who are uninsured or Medicaid-insured have an increased risk of being diagnosed
with late stage cervical cancer. The purpose of this systematic review is to examine the relationship between
the timing of Medicaid enrollment and the stage of cervical cancer at the time of diagnosis to better identify
populations at increased risk.
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Conclusion: The results from this systematic review demonstrate a trend of increased risk of late stage
cervical cancer for women whose enrollment in Medicaid is close to, on, or after diagnosis. Continuous and/
or prolonged enrollment prior to diagnosis was associated with less risk overall, and may be analogous to non-
Medicaid insured women. The increased risk for women who enroll in Medicaid after diagnosis underscores
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Abstract   
 
Background: In 2012, new diagnoses of cervical cancer in the United States are 
estimated to affect 12 170 women, and 4220 women will die from the disease. Despite 
the fact that cervical cancer is easily detected and testing is inexpensive, approximately 
50 percent of those diagnosed will present with late stage disease at the time of diagnosis. 
Women who are uninsured or Medicaid-insured have an increased risk of being 
diagnosed with late stage cervical cancer. The purpose of this systematic review is to 
examine the relationship between the timing of Medicaid enrollment and the stage of 
cervical cancer at the time of diagnosis to better identify populations at increased risk. 
 
 
Method: An exhaustive search of the literature was conducted in Medline (Ovid), 
CINAHL, and Web of Science using the following search terms: Medicaid, neoplasm, 
cervical cancer and uterine cervical neoplasms. Studies that compared Medicaid-insured 
patients and non-Medicaid-insured patients, along with the stage of cervical cancer at the 
time of diagnosis were included.   
 
 
Results: A total of 32 studies were screened, and four studies met the eligibility criteria 
for this systematic review.  One study was defined as a cross-sectional study.  Three 
studies were retrospective cohorts.  All studies included in this review demonstrated an 
increased risk of late stage cervical cancer at the time of diagnosis that was dependent 
upon the timing of Medicaid enrollment. Enrollment prior to diagnosis was associated 
with less risk overall.  Women enrolling in Medicaid at the time of diagnosis were three 
times more likely to present with late stage disease. Women enrolling in Medicaid after 
diagnosis had a five-fold increase in risk.   
 
 
Conclusion: The results from this systematic review demonstrate a trend of increased 
risk of late stage cervical cancer for women whose enrollment in Medicaid is close to, on, 
or after diagnosis. Continuous and/or prolonged enrollment prior to diagnosis was 
associated with less risk overall, and may be analogous to non-Medicaid-insured women. 
The increased risk for women who enroll in Medicaid after diagnosis underscores the 
need to increase outreach to underserved women who do not qualify for Medicaid until 
they have been diagnosed with cervical cancer or precancerous lesions. 
 
 
Keywords:  Medicaid, cervical cancer, cancer stage at diagnosis 
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The Impact of Medicaid Status on the Stage of Cervical Cancer at Time of Diagnosis 
BACKGROUND 
 According to the National Cancer Institute, implementation of cervical cancer 
screenings utilizing the Pap test has reduced mortality from cervical cancer by 75 percent 
nationwide.1 In 2012, new diagnoses of cervical cancer in the United States are estimated 
to affect 12 170 women, and 4220 women will die from the disease.2 
 Cancer stage at diagnosis is strongly associated with survival rate. The 5 year 
relative survival percentage is 90.9 percent for localized cervical cancer, 56.9 percent for 
regional cervical cancer, and 16.5 percent for distant cancer.3 Furthermore, precancerous 
cervical lesions can be detected with the Pap test and treated before becoming cancerous 
and localized disease is amenable to treatment.1-2   
 Despite the fact that cervical cancer is easily detected and testing is inexpensive,1 
approximately 50 percent of those diagnosed will present with late stage disease at the 
time of diagnosis.3 Specific populations and geographic regions in the United States 
continue to have high cervical cancer incidence and death rates.2-3  Women at increased 
risk for mortality from cervical cancer tend to have a lower socio-economic status, have a 
lower level of education, belong to a racial minority, live in rural areas, and be uninsured 
or Medicaid-insured.1,3,11 
 The vast majority of adults enrolled in Medicaid are women whose income is 
below the federal poverty level.6,10   And of those women, nearly two-thirds are between 
the ages of 19 – 44.10   In general, women enrolled in Medicaid share many of the same 
demographic characteristics as those with increased risk for mortality from cervical 
cancer mentioned previously.10,11 Prior to the enactment of The Breast and Cervical 
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Cancer Prevention and Treatment Act of 2000 (BCCPT), women newly diagnosed with 
cervical cancer were eligible for enrollment in Medicaid after diagnosis only if they met 
Medicaid’s enrollment criteria.7,13  Since 2001, The BCCPT Act  has given states the 
option to allow women who are newly diagnosed with breast or cervical cancer to be 
enrolled in Medicaid if they are uninsured and not eligible for Medicaid, less than 65 
years old, and were screened and found to have cancer through the National Breast and 
Cervical Cancer Early Detection Program (NBCCEDP).10,13  Women enrolling in 
Medicaid after a cancer diagnosis are more likely to be impoverished, uninsured, or 
underinsured, with limited access to preventative services.8   
 The purpose of this systematic review is to examine the relationship between the 
timing of Medicaid enrollment and the stage of cervical cancer at the time of diagnosis to 
better identify populations at increased risk.  This review is relevant at this time as many 
states are facing budget shortfalls; and Medicaid, which serves the poorest and sickest,9 is 
facing cuts in services and funding at a time when Medicaid rolls are increasing. 
 
METHODS 
 An exhaustive search of the literature was conducted in Medline (Ovid), 
CINAHL, and Web of Science using the following search terms: Medicaid, neoplasm, 
cervical cancer and uterine cervical neoplasms.  Reference lists of selected articles were 
also reviewed in order to identify additional studies.   
 Studies that compared Medicaid-insured patients and non-Medicaid-insured 
patients, along with the stage of cervical cancer at the time of diagnosis were included.  
Publication time was not limited. 
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 Articles were evaluated for validity using the GRADE criteria.12 Articles were 
placed in the following categories based on the quality of evidence: high, medium, low, 
and very low.  Table 1 summarizes the GRADE system as applied. 
 
RESULTS 
 A total of 32 articles were screened, and four studies5-8 met the eligibility criteria 
for this systematic review.  One study8 was defined as a cross-sectional study.  Three 
studies5-7 were retrospective cohorts. All studies5-8 included in this review demonstrated 
an increased risk of late stage cervical cancer at diagnosis based upon the timing of 
Medicaid enrollment. 
 
Medicaid Status and Stage at Diagnosis of Cervical Cancer   
O’Malley et al (2006) 
 O’Malley et al5 performed a retrospective cohort study utilizing the California 
Cancer Registry (1996 – 1999) and Medicaid enrollment files (1995 – 1999) to compare 
the stage at diagnosis of cervical cancer and Medicaid status (n=888).  Women between 
the ages of 15 and 64 with a diagnosis of cervical cancer as their first invasive cancer and 
whose month of diagnosis was known were included in the analysis.  Non-Medicaid 
(n=3794) enrolled women served as the reference category.  Categories of Medicaid 
enrollment were divided into 3 groups: enrolled in the month of diagnosis (n=142), 
enrolled 1-11 months before diagnosis (intermittent enrollment, n=210), and those 
enrolled continuously in all 12 months (n=536) before diagnosis.  Additional variables of 
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interest were age (15 – 64 years), race, socio-economic status, marital status, and 
histology.5 
 Stage of cancer was defined as: early (local) or late (regional and remote).  Late 
stage cancer at diagnosis was associated with length of Medicaid enrollment:  women 
who enrolled the same month as diagnosis (71% late stage), compared with enrollment 1-
11 months prior to diagnosis (50% late stage), and those enrolled continuously in all 12 
months prior to diagnosis (46%).  In comparison non-Medicaid enrollment was 
associated with late stage at diagnosis of 42.2%.5    
 Women who enrolled in Medicaid during the month of diagnosis were nearly 3 
times more likely to have late stage disease than non-Medicaid enrolled women (adjusted 
OR 2.84; 95% CI = 1.94 – 4.17; p < .05).   Women enrolled in months 1-11 and 
continuously in all 12 months prior to diagnosis had less risk of presenting with late stage 
disease (adjusted OR 1.34; 95% CI = 1.00 – 1.80; p < .05, and adjusted OR 1.08; 95% CI 
= 0.89 – 1.33; p < .05, respectively).  Increasing age was also associated with increased 
risk of presenting with late stage disease: women aged 50 – 59 (adjusted OR 1.84; 95% 
CI = 1.57 – 2.17; p < .05), age 60 – 64 (adjusted OR 2.05; 95% CI = 1.61 – 2.62); p < 
.05).5 
 
Late Stage Cancers in a Medicaid-insured Population 
Bradley et al (2003) 
 Bradley et al, 2003,6 utilized the Michigan Cancer Registry and state Medicaid 
enrollment files from 1996 – 1997 for a retrospective cohort study comparing timing of 
Medicaid enrollment and stage of cancer at diagnosis.  Four common sites of cancer were 
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evaluated using this data: breast, cervical, colorectal, and lung.  In the cervical cancer 
analysis women between the ages of 25 and 64 with a primary cancer were included.  
Non-Medicaid enrollees (n=2945) served as the reference group.  Categories of Medicaid 
enrollment (n=918) were divided into 2 groups: women enrolled in Medicaid one or more 
months prior to the date of diagnosis were considered “Medicaid enrolled before 
diagnosis”.  Women enrolled in the same or later month as the cancer diagnosis were 
considered “Medicaid enrolled after diagnosis”. (2003)6  
 Late stage cancer was defined as regional, distant, or invasive/unknown.  
Medicaid enrollment was associated with increased odds of late stage cervical cancer at 
the time of diagnosis compared to non-Medicaid enrolled women.  Women who enrolled 
in Medicaid before diagnosis were 1.83 times more likely to present with late stage 
cervical cancer (adjusted OR 1.83; 95% CI = 1.28 – 2.63; p < .01).  Women enrolling in 
Medicaid after diagnosis were 5.49 times more likely to present with late stage disease 
(adjusted OR 5.49; 95% CI = 3.71 – 8.11). (2003)6 
 
Health Care Disparities and Cervical Cancer 
Bradley et al (2004) 
 Bradley et al, 2004,7 utilized the same data as the previous study (2003)6 , albeit 
with different headings, for a retrospective cohort study examining the incidence of 
cervical cancer, the stage of cervical cancer at diagnosis and survival between Medicaid-
insured (n=1125) and non-Medicaid-insured women (n=3924).  The sample was stratified 
by age, into 2 groups: those younger than 65 and those aged 65 and older.  Women in the 
Medicaid group were categorized as “enrolled at diagnosis” if enrollment occurred one or 
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more months before diagnosis.  Enrollment during the same month of diagnosis or later 
was considered to be “enrolled after diagnosis”. (2004)7   
 Cervical cancer incidence was higher in the Medicaid-insured group compared to 
the general population.  The incidence rate was higher in all age groups for women 
insured by Medicaid.  The highest incidence for both groups was women between the 
ages 25-29 years.  For this age group, Medicaid-insured women had an incidence rate of 
2.43 per 1000, and the general population had a rate of 1.98 per 1000. (2004)7 
 The stage of cancer at diagnosis was defined as early (in situ or local) or late 
(regional or distant).  In women under the age of 65, diagnosis of late stage cervical 
cancer was higher in the Medicaid group (10%) versus the non-Medicaid group (5%).  
Women enrolled in Medicaid also had a higher percentage die of cervical cancer (6%) 
compared to the non-Medicaid group (2%).   Women aged 65 and older were more likely 
to present with late stage disease (45% vs. 29%) and to die from cervical cancer (29% vs. 
18%). (2004)7  
 Predicted probabilities of late stage cervical cancer at diagnosis were higher for 
women enrolled in Medicaid in both age groups.  In women under age 65 the 
probabilities between non-Medicaid, Medicaid enrollment at diagnosis, and Medicaid 
enrollment after diagnosis were 2%, 4%, and 8%, respectively.  In women aged 65 and 
older the probabilities increased to 21%, 37%, and 58%. (2004)7 
 Hazard ratios were calculated to predict death from cervical cancer.  In women 
younger than 65 years, the hazard ratio for age was 1.06 (95% CI = 1.04 – 1.09, p < .05).  
Women enrolled in Medicaid at the time of diagnosis had a hazard ratio of 1.77 (95% CI 
 13 
= 1.02 – 3.07, p < .05).  And for women enrolled after diagnosis the hazard ratio was 2.4 
(95% CI = 1.49 – 3.86, p < .05). (2004)7 
 Women aged 65 and older had the following hazard ratios: age 1.04 (95% CI = 
1.01 – 1.08, p < .05); Medicaid enrolled at diagnosis 1.15 (95% CI = 0.55 – 2.40, p < 
.05).  Medicaid enrolled after diagnosis 1.24 (95% CI = 0.48 – 3.19, p < .05). (2004)7 
 
Assessing the Effectiveness of Medicaid in Breast and Cervical Cancer Prevention 
Koroukian (2003) 
 Koroukian8 utilized the Ohio Medicaid enrollment files and the Ohio Cancer 
Incidence Surveillance System (OCISS) from 1996-1998 for a cross-sectional study 
comparing stage of breast and cervical cancer at the time of diagnosis between Medicaid-
insured (n=357) and non-Medicaid-insured (n=1095) women.  In the Medicaid-insured 
group, additional comparisons were made between the length and timing of Medicaid 
enrollment with the stage of cancer at diagnosis.  Date of diagnosis was obtained from the 
OCISS and was used to create an enrollment history for the Medicaid group.  
Beneficiaries who were enrolled in the Medicaid program for at least 3 months prior to 
their cancer diagnosis were placed in the “prediagnosis” group (n=225).  The 
“peridiagnosis” group (n=120) consisted of those who were enrolled in the two months 
before cancer diagnosis, at the time of diagnosis, or in the two months following 
diagnosis.  Enrollment three months after diagnosis was the “postdiagnosis” group 
(n=12).   Cases not matched between OCISS and the Medicaid enrollment files were 
identified as the “non-Medicaid” group.  Additional variables of interest across all groups 
were race (African American vs. all others) and age (< 50 – 85+) at time of diagnosis.8 
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 The stage of cervical cancer at diagnosis was stratified to local, regional, and 
distant.  A larger percentage of Medicaid-insured women than non-Medicaid-insured 
women were diagnosed with late stage cervical cancer (local 52.1%, regional 36.7%, 
distant 11.2% vs. 66.3%, 27.9%, and 5.8%, respectively, p < .001).  Stratification based 
on timing of enrollment in the Medicaid group yielded significant differences between 
each subgroup.  Similarities were found between the non-Medicaid group and the 
prediagnosis Medicaid beneficiaries (local 66.3%, regional 27.9%, distant 5.8% vs. 
61.3%, 32.0%, and 6.7%, respectively, p < .001).  Disparities increased when comparing 
the peridiagnosis group and postdiagnosis group (local 35.0%, regional 45.8%, distant 
19.2% vs. 50.0%, 33.3%, and 16.7%, respectively, p < .001).  Differences in age were 
also apparent across the different groups.  In the non-Medicaid group 77.7 percent of 
women were younger than 65 years.  The prediagnosis group was closest to the non-
Medicaid group with 76.4 percent younger than 65 years.  Followed by the postdiagnosis 
group with 83.3 percent and the peridiagnosis group with 90.9 percent younger than 65 
years.8  
 In the analysis of distant stage at diagnosis, the Medicaid prediagnosis group was 
used as a reference group.  Women in the peridiagnosis group were 3.6 times more likely 
to be diagnosed with late stage disease (adjusted OR 3.6; 95% CI = 1.8-7.3).  Likelihood 
of late stage disease was non-significant in the non-Medicaid and postdiagnosis groups 
(adjusted OR 0.9; 95% CI = 0.5 – 1.6, and adjusted OR 2.8; 95% CI = 0.5 – 14.2, 
respectively).8    
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DISCUSSION 
 The four studies5-8 reviewed here differed in how they stratified the Medicaid-
insured population.  However, even with these differences, a pattern emerged of 
increased risk of late stage cervical cancer at the time of diagnosis dependent upon the 
timing of Medicaid enrollment. Taken as a whole, women enrolled in Medicaid had a 
higher risk of late stage disease at the time of diagnosis compared to non-Medicaid-
insured women.  In general, women enrolled in Medicaid prior to diagnosis, had a lower 
risk of late stage cervical cancer at the time of diagnosis when compared with women 
who enrolled after diagnosis.5,7,8  Lower risk was also associated with the length of 
continuous Medicaid enrollment prior to diagnosis.5,8  
 While there are differences between these studies5-8 in terms of the exact timing 
of enrollment in Medicaid, a trend of increased risk emerges for women whose 
enrollment is close to, on, or after diagnosis.  All of the studies5-8 demonstrated a 
substantially increased risk for those enrolled in Medicaid after diagnosis. By stratifying 
timing of enrollment to include those enrolled several months prior to diagnosis, 
O’Malley et al5 and Koroukian8 demonstrate the risk for Medicaid enrollees to be similar 
as for women in the non-Medicaid-insured groups.  This is in stark contrast to the nearly 
doubling of risk seen in the Bradley et al, 2003,6 study which categorized enrollment 
prior to diagnosis more broadly than the other studies.5,8   
  O’Malley et al5 stratified women enrolled in Medicaid prior to diagnosis into 2 
groups. Women who were enrolled continuously for all 12 months prior to diagnosis had 
an adjusted odds ratio that was not statistically significant when compared to non-
Medicaid-insured women.  Women enrolled for 1 – 11 months (intermittent) prior to 
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diagnosis had more risk comparatively (adjusted OR 1.34), but substantially less risk than 
those enrolled after diagnosis. The results from this study5 suggest that continuous 
enrollment in Medicaid may be analogous to non-Medicaid enrollment in terms of risk of 
presenting with late stage disease.  Koroukian8 stratified the Medicaid-insured population 
into 3 groups, which yielded considerable differences in risk. In this study8, the 
prediagnosis group (enrolled at least 3 months prior to diagnosis) along with non-
Medicaid-insured women showed no significant differences in risk of presenting with late 
stage cervical cancer at the time of diagnosis. Bradley et al, 2003,6 found that women 
enrolled at least one month or longer prior to diagnosis were nearly twice as likely to 
have late stage disease than women not enrolled in Medicaid. This finding demonstrates a 
much larger increase in risk in women who enrolled in Medicaid prior to diagnosis than 
the other studies.5,8  However, it is not possible to differentiate if the increased risk is the 
same for all women who enrolled prior to diagnosis because it is unknown when women 
in this group were enrolled in Medicaid.  It is possible that stratifying the timing of 
enrollment would yield a different result in terms of risk.   These contradictory results 
underscore the need for future studies to stratify those enrolled prior to diagnosis to 
conclude if longer Medicaid and/or continuous enrollment carries less risk than 
enrollment just prior to diagnosis.  
 All of the studies5,7,8 that examined the risk of late stage disease and Medicaid 
enrollment at the time of diagnosis found substantially increased risk within this group. 
O’Malley et al5 found a nearly 3-fold increase in risk in this group.  In Koroukian8 the 
peridiagnosis group (enrollment 2 months before, at the time of diagnosis, and 2 months 
following diagnosis) had a statistically significant increase in risk (adjusted OR 3.6) of 
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late stage diagnosis.  Bradley et al, 2004,7 found an increased incidence in cervical 
cancer, increased probability of late stage cancer at diagnosis, and increased risk of death 
from cervical cancer among women enrolling in Medicaid at the time of diagnosis 
compared with non-Medicaid-insured women. This study7 finds that for women under the 
age of 65, risk of death from cervical cancer is 1.77 times higher for women enrolled in 
Medicaid at the time of diagnosis.  It should be noted that while this group was defined as 
women enrolling in Medicaid at the time of diagnosis, the timing of enrollment was 
actually one or more months prior to diagnosis, and thus may be underestimating the risk 
in women enrolled at the time of diagnosis as compared to the other studies.5,8 
 Three studies6-8 examined the risk of late stage disease in women who enrolled in 
Medicaid after diagnosis. Koroukian8 categorized women enrolled three or more months 
after diagnosis as the “postdiagnosis” group. This group showed no significant difference 
in risk compared to the non-Medicaid group, which is in contrast to the other studies,6,7 
and may be due to the small sample size. The postdiagnosis group in this study was quite 
small (12 out of 357 total), compared to the other Medicaid groups.  In Bradley et al, 
2003,6 women younger than 65 years enrolled in Medicaid the same month or after 
diagnosis were 5 times more likely to present with late stage cervical cancer than women 
not enrolled in Medicaid.  This is a striking increase in risk to women enrolling at the 
time of diagnosis or later.  In order to better understand the substantially increased risk of 
this group, it would be of value to further stratify this second group into those enrolling at 
time of diagnosis and those women enrolling several months after diagnosis.  Bradley et 
al, 2004,7 also demonstrates a much greater risk of late stage diagnosis and death from 
cervical cancer for women under the age of 65 who were enrolled in Medicaid after 
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diagnosis (HR 2.4).  Multiple factors could be contributing to this elevated risk of death 
aside from the association between late stage cancer at diagnosis and increased mortality.   
For instance, disenrollment from Medicaid, which would then limit access to care, is a 
potential variable that could also be a factor in the increased mortality rate in this group.  
Additional studies are needed to determine the factors involved in the increased risk of 
death in this group. 
 Interestingly, while age was associated with an increased risk in death in women 
aged 65 and older in this study,7 Medicaid enrollment was not associated with a 
statistically significant increased risk of death despite an increased probability of late 
stage disease at the time of diagnosis (58% vs. 21% for non-Medicaid-insured).  If this 
trend is indeed indicative of the survival rates in this older population, one possibility that 
may explain this difference is the potential for dual eligibility with Medicare,10 which 
may yield more consistent access to health care compared with Medicaid alone.  
Additional studies examining mortality and the risk of late stage disease are needed, 
especially when compared to the increased risk of death in the younger Medicaid-insured 
population.  The difference in the death rate from cervical cancer between these two age 
groups is significant as is the difference between the death rate and timing of enrollment.   
 A limitation shared by all of the studies5-8 reviewed here was the inability to 
establish the insurance status of the non-Medicaid group.  Whether women had private 
insurance, were underinsured, or uninsured is not known.  What is known is that this 
group was not enrolled in Medicaid.  Since the insurance status of this group was 
unknown, the non-Medicaid group could have included underinsured or uninsured 
women who were not enrolled in Medicaid.  It is then possible that the inclusion of these 
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women in the non-Medicaid group could actually cause an underestimation of risk 
comparatively. 
 A second limitation was the varying criteria each study used for timing of 
enrollment.  While a pattern emerged across all of the studies5-8, that women enrolled in 
Medicaid had an increased risk of late stage diagnosis, the risk varied greatly between 
each study based upon the timing and length of Medicaid enrollment and how each group 
was stratified.     
 The GRADE assessment tool12 was used to assess the quality of each study.   The 
studies5-8 included in this review were all observational studies and therefore, given an 
initial quality rating of low.  None of the studies5-8 were downgraded based on the 
GRADE criteria. 
  
CONCLUSION 
 The results from this systematic review demonstrate a trend of increased risk of 
late stage cervical cancer for women whose enrollment in Medicaid is close to, on, or 
after diagnosis. The risk of late stage disease at the time of diagnosis was dependent upon 
the timing of Medicaid enrollment and increased significantly for women who enrolled at 
the time of, or after diagnosis.  Continuous and/or prolonged enrollment prior to 
diagnosis was associated with less risk overall, and may be analogous to non-Medicaid-
insured women. Risk of death from cervical cancer was significantly higher in women 
enrolled in Medicaid under the age of 65 years, but not for women aged 65 and older.   
More studies are needed to examine the relationship between the timing of Medicaid 
enrollment and late stage disease to allow for more effective targeting of at-risk 
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populations. The increased risk for women who enroll in Medicaid after diagnosis, as 
demonstrated in this review, underscores the need to increase outreach to underserved 
women who do not qualify for Medicaid until they have been diagnosed with cervical 
cancer or precancerous lesions. 
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TABLE I. Characteristics of Reviewed Studies 
Quality Assessment 
Summary of Findings 
Importance Number of Patients 
Quality 
Design Limitations Indirectness Imprecision Inconsistency Other Considerations Case Control 
O'Malley,C.D.; Shema,S.J.; Clarke,L.S.; Clarke,C.A.; Perkins,C.I.  Medicaid status and stage at diagnosis of cervical cancer.   
Am.J.Public Health, 2006, 96, 12, 2179-2185 
Retrospective 
Cohort 
No 
limitations 
No 
indirectness 
No 
imprecision 
No 
inconsistencies 
Underestimation 
of risk 888 3794 
⊕⊕ΟΟ 
Low Critical 
Bradley,C.J.; Given,C.W.; Roberts,C.  Late stage cancers in a Medicaid-insured population.   
Med.Care, 2003, 41, 6, 722-728 
Retrospective 
Cohort 
No 
limitations 
No 
indirectness 
No 
imprecision 
No 
inconsistencies 
Underestimation 
of risk 918 2945 
⊕⊕ΟΟ 
Low Critical 
Bradley,C.J.; Given,C.W.; Roberts,C. Health care disparities and cervical cancer. 
Am.J.Public Health, 2004, 94, 12, 2098-2103 
Retrospective 
Cohort 
No 
limitations 
No 
indirectness 
No 
imprecision 
No 
inconsistencies 
Underestimation 
of risk 1125 3924 
⊕⊕ΟΟ 
Low Critical 
Koroukian,S.M.  Assessing the effectiveness of Medicaid in breast and cervical cancer prevention.   
Journal of Public Health Management & Practice, 2003, 9, 4, 306-314 
Cross-
sectional 
study 
No 
limitations 
No  
indirectness 
No 
imprecision 
No 
inconsistencies 
Underestimation 
of risk 357 1095 
⊕⊕ΟΟ 
Low Critical 
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TABLE II. Summary of Finding 
 
                               
Number of participants with late stage 
disease+ 
 
 
Risk of late stage diagnosis** 
 
 
Study 
 
Non-Medicaid 
Enrolled (%) 
 
Medicaid 
Enrolled (%) 
 
Medicaid enrolled before 
diagnosis 
Medicaid 
enrolled at 
time of 
diagnosis 
 
Medicaid 
enrolled after 
diagnosis 
O’Malley et 
al5 
(2006) 
1599 (42.1) 451 (50.8)  Adjusted OR (95% CI)  
1-11 mo 
before 
diagnosis 
12 mo before 
diagnosis 
 
1.34 (1.00-
1.80) 
1.08 (0.89-
1.33) 
2.84 (1.94-
4.17) 
-- 
Bradley et 
al6  (2003) 
157 (5) 102 (11) OR (95% CI)  
1.83 (1.28-2.63) -- 5.49 (3.71-8.11) 
Bradley et 
al7 (2004) 
Women < 65 y/o Predicted probabilities++ 
178 (4.88) 109 (10.25) -- 4%  8% 
Prediction of Death  
Hazard Ratio (95% CI) 
1.77 (1.02-
3.07) 
2.4 (1.49-3.86) 
Women 65 y/o or older Predicted probabilities++ 
79 (28.52) 28 (45.16) -- 33% 58% 
Prediction of Death  
Hazard Ratio (95% CI) 
1.15 (0.55-
2.40) 
1.24 (0.48-
3.19) 
Koroukian8 
(2003) 
369 
(33.7) 
171 
(47.9) 
Adjusted OR (95% CI) 
1 3.6 (1.8-7.3) 2.8 (0.5-14.2) 
+   Late stage disease defined as regional or distant or (invasive/unknown) 
++ Probability for non-Medicaid insured: women < 65 y/o is 2%; women 65 y/o or older is 27% 
**  Studies had differing criteria for each enrollment period 
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FIGURE I: Cervical Cancer Mortality Rates by County1 
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